The connection between the CHD gene and autism-related gastrointestinal (GI) manifestations.
FDA rejects Eli Lilly’s eczema drug due to third-party manufacturing issues
FDA has rejected Eli Lilly’s eczema treatment lebrikizumab due to issues found at an unnamed third-party manufacturer. According to a press release, a “multi-sponsor” inspection